Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

5.8%

3 terminated/withdrawn out of 52 trials

Success Rate

93.9%

+7.4% vs industry average

Late-Stage Pipeline

38%

20 trials in Phase 3/4

Results Transparency

0 of 46 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1

18(40.9%)

Phase 4

11(25.0%)

Phase 3

9(20.5%)

Phase 2

4(9.1%)

N/A

2(4.5%)

44Total

Phase 1(18)

Phase 4(11)

Phase 3(9)

Phase 2(4)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (52)

Showing 20 of 52 trials

NCT07151118Recruiting

ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer

Role: collaborator

NCT07102719Phase 1Completed

Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

Role: lead

NCT06889350Phase 1Completed

Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

Role: lead

NCT06627322Not ApplicableRecruiting

A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)

Role: collaborator

NCT06339788Phase 1Completed

Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

Role: lead

NCT05337683Completed

A Retrospective Non-Interventional Study to Evaluate the Impact of Eculizumab in Korean PNH Patients

Role: lead

NCT04492033Phase 1Terminated

A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients

Role: lead

NCT02024100Completed

Observational Study to Investigate the Effectiveness of Eprosartan on Pulse Pressure (Teveten_MS)

Role: lead

NCT03460301Completed

Observational of PNH Type Cells in Korean Patients With Bone Marrow Failure Syndrome and Having Hemolytic PNH

Role: lead

NCT02512523Phase 4Completed

Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)

Role: lead

NCT05504226Phase 3Completed

Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin

Role: lead

NCT03793023Completed

Observational Study to Evaluate the Efficacy and Safety of Teneligliptin

Role: lead

NCT05405777Completed

A Retrospective Study to Evaluate the Clinical Outcome According to Treatment in aHUS Patients in South Korea

Role: lead

NCT05504239Phase 3Completed

Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin and Metformin

Role: lead

NCT05663073Phase 1Completed

Pharmacokinetics of Irbesartan/Amlodipine FDC and Co-administration of Irbesartan and Amlodipine in Healthy Volunteers

Role: lead

NCT05688098Phase 1Completed

Pharmacokinetics of Irbesartan/Amlodipine High FDC and Co-administration of Irbesartan and Amlodipine High in Healthy Volunteers

Role: lead

NCT05475665Phase 3Completed

Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients

Role: lead

NCT05476354Phase 3Completed

Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients

Role: lead

NCT05688085Phase 1Completed

Pharmacokinetics of Irbesartan High/Amlodipine FDC and Co-administration of Irbesartan High and Amlodipine in Healthy Volunteers

Role: lead

NCT03508323Phase 4Completed

Tenelia Elderly CGMS Study(TEDDY)

Role: lead